Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS).

Subjects

Subjects :

*STROKE
*JOHN Cunningham virus
*PSORIATIC arthritis
*CLINICAL trials

Details

Language :

English

ISSN :

00070963

Volume :

188

Issue :

6

Database :

Academic Search Index

Journal :

British Journal of Dermatology

Publication Type :

Academic Journal

Accession number :

164284189

Full Text :

https://doi.org/10.1093/bjd/ljad039